Tim Illidge - Dissemin

Papers authored by Tim Illidge

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2014 Barbara Pro, Ranjana Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge

, Jeffrey Matous, Radhakrishnan Ramchandern, Michelle A. Fanale, Joseph M. Connors, Yinghui Wang, Dirk Huebner, Dana A. Kennedy, Andrei R. Shustov

Four-Year Survival Data from an Ongoing Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Upload

This paper is made freely available by the publisher.

R. Dummer, M. Duvic, J. Scarisbrick, E. A. Olsen, S. Rozati, N. Eggmann, S. M. Goldinger, K. Hutchinson, L. Geskin, T. M. Illidge

, E. Giuliano, J. Elder, Y. H. Kim, Duvic M Scarisbrick J Olsen EA Rozati S Eggmann N Goldinger SM Hutchinson K Geskin L Illidge TM Giuliano E Elder J Kim Yh Dummer R.

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)

Download from academic.oup.com

2013 Tim M. Illidge

, Eleanor J. Cheadle, Jamie Honeychurch

New opportunities for anti-CD20 monoclonal antibody to give a direct punch to the tumor

Download from www.tandfonline.com

Adam Gibb, Alastair Greystoke

, Malcolm R. Ranson, Kim M. Linton, Susan M. Neeson, G. Hampson, Timothy M. Illidge

, Ed Smith, Caroline Dive, A. Pettitt, A. Lister, P. Johnson, John A. Radford, Greystoke A Ranson M Linton K Neeson S Hampson G Illidge T Smith E Dive Ca Pettitt A Lister A Johnson P Radford J. Gibb A.

A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity

Download from www.nature.com

Timothy M. Illidge

, Clara Chan, N. Counsell, S. Morris, J. Scarisbrick, D. Gilson, Bilyana Popova, P. Patrick, P. Smith, S. Whittaker, Richard A. Cowan, Chan C Counsell N Morris S Scarisbrick J Gilson D Popova B Patrick P Smith P Whittaker S Cowan R. Illidge T.

Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma

Download from www.nature.com

R. Cooke, M. E. Jones, D. Cunningham, S. J. Falk, D. Gilson, B. W. Hancock, S. J. Harris, A. Horwich, P. J. Hoskin, A. M. Stevens, Tim Illidge

, I. Syndikus, M. V. Williams, D. C. Linch, A. J. Swerdlow and 57 other authors

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

Download from doi.org

Distributing this paper is prohibited by the publisher

Sally Arai, Michelle Fanale, Sven deVos, Andreas Engert, Tim Illidge

, Peter Borchmann, Anas Younes, Franck Morschhauser, Alex McMillan, Sandra J. Horning

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

Upload

M. Fanale, S. DeVos, A. Engert, Tim Illidge

, P. Borchmann, A. Younes, F. Morschhauser, Horning Sj, Fanale M deVos S Engert A Illidge T Borchmann P Younes A Morschhauser F Horning Sj Arai S.

Defining a Hodgkin Lymphoma Population for Novel Therapeutics after Relapse from Autologous haematopoietic Cell Transplantation

Upload

J. Honeychurch, C. Dive, Tim Illidge

, Dive C Illidge Tm Honeychurch J.

Synchronouse apoptosis in established tumour leads to the induction of adaptive immunity

Upload

This paper is available in a repository.

Jamie Honeychurch, C. Dive TM Illidge J. Honeychurch, Caroline Dive, Timothy M. Illidge

, Dive C Illidge Tm Honeychurch J.

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity

Download from www.ncbi.nlm.nih.gov

Eleanor J. Cheadle, Lauren Sidon, Simon J. Dovedi, Monique H. M. Melis, Waleed Alduaij, Tim M. Illidge

, Jamie Honeychurch, Sidon L. Dovedi SJ Melis MH Alduaij W. Illidge TM Honeychurch J. Cheadle Ej

The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab.

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

Jamie Honeychurch, Monique H. M. Melis, Simon J. Dovedi, Lijun Mu, Timothy M. Illidge

, Melis MH Dovedi SJ Mu L. Illidge Tm-M. Honeychurch J.

Immunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populations.

Upload

M. H. M. Melis, Kathryn L. Simpson, Kl Simpson2 SJ Dovedi A Welman M MacFarlane C Dive J Honeychurch* and Tm Illidge* (joint senior authors) Mhm Melis1, Arkadiusz Welman, Simpson KL* Dovedi SJ Welman A Macfarlane M Dive C Honeychurch J Illidge T.-M. Melis Mh*, Simon J. Dovedi, M. MacFarlane, Caroline Dive, Jamie Honeychurch, Timothy M. Illidge

, Simpson KL Dovedi SJ Welman A Macfarlane M Dive C Honeychurch J Illidge T.-M. Melis Mh

Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response

Download from www.nature.com

S. J. Dovedi, G. Lipowska-Bhalla, S. A. Beers, M. J. Glennie, T. M. Illidge

, J. Honeychurch

The role of antigen-presenting cell subsets in directing antilymphoma immune responses to radiation induced tumour cell death in combination with anti-CD40 monoclonal antibody

Upload

Barbara Pro, Ranjana H. Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge

, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A. Fanale, Joseph M. Connors, Yin Yang, Dirk Huebner, Dana A. Kennedy, Andrei R. Shustov

Three-Year Survival Results From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Systemic Anaplastic Large Cell Lymphoma

Upload

Simon Dovedi, M. H. M. Melis, R. W. Wilkinson, A. L. Adlard, Ian Stratford, Jamie Honeychurch, Tim Illidge

Systemic delivery of a TLR7 agonist in combination with radiation primes durable anti-tumor immune responses in mouse models of lymphoma.

Upload

Lena Specht, Joachim Yahalom, Tim Illidge

, Anne Kiil Berthelsen, Louis S. Constine, Hans Theodor Eich, Theodore Girinsky, Richard T. Hoppe, Peter Mauch, N. George Mikhaeel, Andrea Ng, Yahalom J Illidge T Berthelsen AK Constine LS Eich HT Girinsky T Hoppe RT Mauch P Mikhaeel NG Ng A. Specht L.

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Upload

E. J. Cheadle, L. Sidon, S. J. Dovedi, M. H. Melis, W. Alduaij, T. M. Illidge

, J. Honeychurch

Induction of immunogenic cell death by anti-CD20 antibodies

Upload

2012 Scarisbrick Jj, J. J. Scarisbrick, S. Morris, R. Azurdia, Tim Illidge

, E. Parry, R. Graham Brown, A. S. Wierzbicki, R. Cowan, E. Gallop Evans, R. Wachsmuth, M. Eagle, Wierzbicki As, H. Soran, S. Whittaker and 2 other authors

UK Consensus Statement on Safe Clinical Prescribing of Bexarotene for Patients with Cutaneous T-cell Lymphoma

Download from www.researchgate.net

Ng G. Burnet, Lj J. Billingham, Csk S. K. Chan, E. Hall, J. Macdougall, Ri I. Mackay, Ts S. Maughan, Cm M. Nutting, Jn N. Staffurth, Tm M. Illidge

, Billingham LJ Chan CS Hall E Macdougall J Mackay RI Maughan TS Nutting CM Staffurth JN Illidge TM;on behalf of the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Executive Group Burnet Ng

Methodological Considerations in the Evaluation of Radiotherapy Technologies

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Tim Illidge